Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrer

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Journal of Medicinal Chemistry|June 13, 2022
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward MetastasisKevin J Frankowski, Samarjit Patnaik, Chen Wang, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
The Journal of Infectious Diseases|September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug DevelopmentRobert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Science Translational Medicine|November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGrant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
An OpenData portal to share COVID-19 drug repurposing data in real timeKyle R Brimacombe, Tongan Zhao, Richard T Eastman, et al.
Science (New York, N.Y.)|September 5, 2024
The use of ectopic volar fibroblasts to modify skin identitySam S Lee, Evan Sweren, Erika Dare, et al.
Science Translational Medicine|February 14, 2020
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responsesJesse M Jaynes, Rushikesh Sable, Michael Ronzetti, et al.
Plos One|July 15, 2021
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALKLong-Sheng Chang, Janet L Oblinger, Abbi E Smith, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Journal of Medicinal Chemistry|June 13, 2022
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward MetastasisKevin J Frankowski, Samarjit Patnaik, Chen Wang, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
The Journal of Infectious Diseases|September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug DevelopmentRobert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Science Translational Medicine|November 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screeningGrant L Lin, Kelli M Wilson, Michele Ceribelli, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
An OpenData portal to share COVID-19 drug repurposing data in real timeKyle R Brimacombe, Tongan Zhao, Richard T Eastman, et al.
Science (New York, N.Y.)|September 5, 2024
The use of ectopic volar fibroblasts to modify skin identitySam S Lee, Evan Sweren, Erika Dare, et al.
Science Translational Medicine|February 14, 2020
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responsesJesse M Jaynes, Rushikesh Sable, Michael Ronzetti, et al.
Plos One|July 15, 2021
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALKLong-Sheng Chang, Janet L Oblinger, Abbi E Smith, et al.
Pageof 30